Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 10/20 | 0.38 |
| ▸ | GSK3A | P49840 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HCRTR1 | O43613 | 3/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7461597 | 0.89 | KCNN4 (0.41) | PIM1KCNN4GSK3AGSK3BALDH1A1 | |
| SCHEMBL7462920 | 0.88 | PIM1 (0.40) | PIM1KCNN4GSK3AGSK3BALDH1A1 | |
| SCHEMBL7455705 | 0.88 | PIM1 (0.40) | PIM1KCNN4GSK3AGSK3BALDH1A1 | |
| SCHEMBL7468116 | 0.86 | PIM1 (0.42) | PIM1KCNN4GSK3AGSK3BALDH1A1 | |
| SCHEMBL7459070 | 0.83 | KCNN4 (0.42) | KCNN4GSK3AGSK3BALDH1A1POLB | |
| SCHEMBL7463920 | 0.80 | PIM1 (0.40) | PIM1KCNN4GSK3AGSK3BALDH1A1 | |
| SCHEMBL7458779 | 0.79 | PIM1 (0.41) | PIM1KCNN4GSK3AGSK3BALDH1A1 | |
| SCHEMBL7462919 | 0.78 | PIM1 (0.41) | PIM1GSK3AGSK3BALDH1A1POLB | |
| SCHEMBL7459751 | 0.76 | PIM1 (0.39) | PIM1GSK3AGSK3BALDH1A1POLB | |
| SCHEMBL7469002 | 0.76 | PIM1 (0.43) | PIM1KCNN4GSK3AGSK3BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1214305-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION | Maxia Pharmaceuticals, Inc. (US) | 2002-06-19 | — | — | EP | claimed |
| WO-2001016123-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION | MAXIA PHARMACEUTICALS, INC. (US) | 2001-03-08 | — | — | WO | claimed |
| EP-1214305-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION | Maxia Pharmaceuticals, Inc. (US) | 2002-06-19 | — | — | EP | disclosed |
| WO-2001016123-A1 | BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION | MAXIA PHARMACEUTICALS, INC. (US) | 2001-03-08 | — | — | WO | disclosed |